Company Filing History:
4 out of 525 
3 out of 3 
3 out of 560 
Years Active: 2013-2019
Title: Innovations of Serhiy Souchelnytskiy in Cancer Therapy
Introduction
Serhiy Souchelnytskiy is a prominent inventor based in Stockholm, Sweden. He has made significant contributions to the field of cancer therapy through his innovative research and development of antibodies. With a total of four patents to his name, his work focuses on targeting specific membrane transporters to enhance cancer treatment.
Latest Patents
Souchelnytskiy's latest patents include groundbreaking inventions related to antibodies directed to the membrane transporter NaP12b (SLC34A2). These patents detail the use of SLC34A2 as a target for immunotherapy, particularly in the treatment of ovarian cancer. The SLC34A2 epitope peptide, which encompasses amino acids 312-340, has been identified as a crucial component in generating antibodies that exhibit anti-tumor activity. His inventions also encompass methods for generating immune responses and screening compounds directed against SLC34A2.
Career Highlights
Throughout his career, Souchelnytskiy has worked with esteemed organizations such as the Ludwig Institute for Cancer Research and the Institute of Molecular Biology and Genetics at the National Academy of Sciences of Ukraine. His research has significantly advanced the understanding of cancer therapies and the development of targeted treatments.
Collaborations
Some of his notable coworkers include Gerd J Ritter and Beatrice Yin. Their collaborative efforts have contributed to the success of his research and the advancement of cancer treatment methodologies.
Conclusion
Serhiy Souchelnytskiy is a distinguished inventor whose work in cancer therapy has the potential to transform treatment options for patients. His innovative patents and collaborations highlight his commitment to advancing medical science and improving patient outcomes.